Asklepios BioPharmaceutical has a total of 281 patents globally, out of which 38 have been granted. Of these 281 patents, more than 71% patents are active. The United States of America is where Asklepios BioPharmaceutical has filed the maximum number of patents, followed by Europe and United Kingdom. Parallelly, The United Kingdom seems to be the main focused R&D center and also USA is the origin country of Asklepios BioPharmaceutical.
Asklepios BioPharmaceutical was founded in 2001. The Company operates as an AAV gene therapy company. The Company offers end-to-end gene therapy platform includes scaled-up manufacturing with its Pro10 cell line, AAV capsid library and clinical programs for a range of genetic disease indications.
Do read about some of the most popular patents of Asklepios BioPharmaceutical which have been covered by us in this article and also you can find Asklepios BioPharmaceutical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Asklepios BioPharmaceutical patent portfolio.
How many patents does the Founder and CEO of Asklepios BioPharmaceutical have?
The Founder Jude Samuski has 0 patent, R. Jude Samulski has 5 patents and Sheila Ann Mikhail has 0 patents and the CEO Gustavo Pesquin has 0 patent.
How many patents does Asklepios BioPharmaceutical have?
Asklepios BioPharmaceutical has a total of 281 patents globally. These patents belong to 65 unique patent families. Out of 281 patents, 201 patents are active.
How Many Patents did Asklepios BioPharmaceutical File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Asklepios BioPharmaceutical Applications Filed||Asklepios BioPharmaceutical Patents Granted|
How many Asklepios BioPharmaceutical patents are Alive/Dead?
How Many Patents did Asklepios BioPharmaceutical File in Different Countries?
Countries in which Asklepios BioPharmaceutical Filed Patents
|United States Of America||35|
|Hong Kong (S.A.R.)||24|
Where are Research Centers of Asklepios BioPharmaceutical Patents Located?
10 Best Asklepios BioPharmaceutical Patents
US7001761B2 is the most popular patent in the Asklepios BioPharmaceutical portfolio. It has received 55 citations so far from companies like Sarepta Therapeutics, Bamboo Therapeutics and Solid Biosciences.
Below is the list of 10 most cited patents of Asklepios BioPharmaceutical:
|Publication Number||Citation Count|
What Percentage of Asklepios BioPharmaceutical US Patent Applications were Granted?
Asklepios BioPharmaceutical (Excluding its subsidiaries) has filed 19 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 72.73%.
Below are the key stats of Asklepios BioPharmaceutical patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Asklepios BioPharmaceutical?
|Law Firm||Total Applications||Success Rate|
|Ronald I Eisenstein||16||88.89%|
|Moore & Van Allen||2||0.00%|
What are Asklepios BioPharmaceutical key innovation segments?
What Technologies are Covered by Asklepios BioPharmaceutical?
The chart below distributes patents filed by Asklepios BioPharmaceutical